Description

8-[4-(1H-Benzimidazol-2-Yl)Butyl]-1,3-Dimethyl-1H-Purine-2,6(3H,7H)-Dione is a high-purity, complex heterocyclic organic compound that serves as a critical advanced intermediate in pharmaceutical research and development. This molecule is valued for its unique structural framework, which combines benzimidazole and purine moieties, making it a versatile building block for creating novel bioactive molecules. It is primarily sought after by research institutions and pharmaceutical companies engaged in the synthesis of potential therapeutic agents, particularly in areas like enzyme inhibition and receptor modulation. Our supply ensures consistent quality and reliable availability for your most demanding synthesis projects.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates targeting various disease pathways.
• Biochemical Research: Used as a reference standard or building block in medicinal chemistry for structure-activity relationship (SAR) studies.
• Enzyme Inhibitor Development: Its structural features make it a candidate scaffold for designing inhibitors of kinases, phosphodiesterases, or other purine-binding enzymes.
• Organic Synthesis: Employed in complex multi-step organic syntheses to introduce specific heterocyclic functionalities.
• Life Science Reagents: Potential use in the development of specialized biochemical reagents and probes for cellular studies.

Basic Information

Product Name	8-[4-(1H-Benzimidazol-2-Yl)Butyl]-1,3-Dimethyl-1H-Purine-2,6(3H,7H)-Dione
CAS No.	74039-64-8
Molecular Formula	C₁₈H₂₂N₆O₂
Molecular Weight	354.41 g/mol
Synonyms	1,3-Dimethyl-8-[4-(1H-benzimidazol-2-yl)butyl]-3,7-dihydro-1H-purine-2,6-dione; 8-[4-(1H-Benzimidazol-2-yl)butyl]-1,3-dimethylxanthine; 1,3-Dimethyl-8-[4-(2-benzimidazolyl)butyl]xanthine; 8-(4-(1H-Benzo[d]imidazol-2-yl)butyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione; Pentoxifylline Impurity; Pentoxifylline Related Compound; Contact for additional synonyms.
EINECS	Contact for details

Quality Control

Our 8-[4-(1H-Benzimidazol-2-Yl)Butyl]-1,3-Dimethyl-1H-Purine-2,6(3H,7H)-Dione is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (IR, NMR), to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing all test results and specifications is provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.